Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

Investment proposals will cost taxpayers - Spanish MEP Zalba Bidegain again happy to act as a puppet for outside interests

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska

Brussels, 31 March 2011 – EU member states – and taxpayers – are risking legal action from foreign companies as a result of new international investment policies currently being discussed by the EU. A new report by Corporate Europe Observatory, Investment Rights Stifle Democracy, highlights how industry lobby groups, law firms and member states acting in their interest have manipulated proposals in order to weaken safeguards for governments and citizens [1]. 

Under the new rules, which will be voted on in Parliament next week, investors from China, India or elsewhere could sue EU member states if they find that a law in the area of public health, environmental protection or social policy interferes with their profits. Similar rules have already led to claims of millions of Euros against the German and Slovak governments, after foreign investors objected to national legislation, with taxpayers paying the price. In Uruguay, the tobacco company Philip Morris initiated proceedings against proposals to include health warnings on cigarette packs, arguing it would create a substantial loss of market share. 

Report author Pia Eberhardt said:

It is only a matter of time until European taxpayers will have to compensate multinationals with hundreds of millions of Euros because companies don't like policies which hamper their profits. Cases have already been brought in several countries, objecting to environmental regulations and health protection measures. There is a real danger that policy-makers will shy away from regulations in the interest of their citizens, for fear of these excessive claims. Politicians and national governments appear to think they are acting in the interests of EU investors overseas, but they are in fact exposing themselves to predatory action from foreign investors in Europe.”

 'Investment Rights Stifle Democracy’ also reveals that a number of MEPs from the European People’s Party have tabled industry-biased amendments to axe proposals for a more balanced investment regime. One of the MEPs highlighted is Pablo Zalba Bidegain, the Spanish MEP who was exposed by undercover journalists last weekend for having agreed to table amendments in the Parliament in return for payment. 

Carl Schlyter MEP, one of the Parliament’s rapporteurs on the investment discussion, told CEO he had never seen such an extreme example of MEPs focusing solely on big business interests [2]. 

More than 170 European civil society organisations have urged MEPs to champion a balanced investment policy that holds corporations accountable and protects the right to regulate in favour of public interest, decent work, human rights and environmental sustainability [3].

Contact:

Pia Eberhardt, pia[at]corporateeurope.org

Notes:

[1] The report, Investment rights stifle democracy, can be downloaded here: http://www.corporateeurope.org/publications/investment-rights-stifle-dem...

[2] Interview with MEP Carl Schlyter: Lobbyism is the main reason for bad policies in the EU: http://www.corporateeurope.org/global-europe/blog/pia/2011/03/24/mep-lob...

[3] Civil society statement: Just EU investment policy now!: http://www.s2bnetwork.org/themes/eu-investment-policy.html

Related issues: 
 
An often asked question is whether TTIP will weaken Europe's rules over genetically modified organisms (GMOs). Meanwhile, the biotech industry is pushing for the products of the 'next generation' biotech crops to escape the EU's legislation on GMOs and therefore to go unregulated. Is there a link between this new push, and TTIP? Emails obtained via a Freedom of Information request show this might indeed be the case.
An investigation led by research and campaign group Corporate Europe Observatory (CEO) and journalist Stéphane Horel exposes corporate lobby groups mobilising to stop the EU taking action on hormone (endocrine) disrupting chemicals (EDCs). The report sheds light on how corporations and their lobby groups have used numerous tactics from the corporate lobbying playbook: scaremongering, evidence-discrediting, and delaying tactics as well as the ongoing TTIP negotiations as a leverage.
CEO undertook a survey to try and establish which law firms and lobby consultancies were willing to be transparent about their lobbying on TTIP.
The European Commission’s shocking leaked proposal for ”better regulation” would create pro-business bureaucratic mechanisms to prevent new laws - from regulating chemicals to preventing climate change - that could hurt the bottom line of corporations. Add TTIP and its 'regulatory co-operation' and US companies get in on the act too, with extra privileges.
Sign the petition to ‪cancel Greek debt‬
An often asked question is whether TTIP will weaken Europe's rules over genetically modified organisms (GMOs). Meanwhile, the biotech industry is pushing for the products of the 'next generation' biotech crops to escape the EU's legislation on GMOs and therefore to go unregulated. Is there a link between this new push, and TTIP? Emails obtained via a Freedom of Information request show this might indeed be the case.
Following the publication of the Carte Blance for Fracking report earlier this year, CEO and Friends of the Earth Europe have submitted a complaint to the European Ombudsman about the industry dominated advisory group convened by the Commission to get fracking introduced through the back door.
Corporate Europe Forum